319 related articles for article (PubMed ID: 15215182)
21. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
[TBL] [Abstract][Full Text] [Related]
22. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
23. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease.
Urbanc B; Cruz L; Le R; Sanders J; Ashe KH; Duff K; Stanley HE; Irizarry MC; Hyman BT
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):13990-5. PubMed ID: 12374847
[TBL] [Abstract][Full Text] [Related]
24. Reverse relationship between beta-amyloid precursor protein and beta-amyloid peptide plaques in Down's syndrome versus sporadic/familial Alzheimer's disease.
Egensperger R; Weggen S; Ida N; Multhaup G; Schnabel R; Beyreuther K; Bayer TA
Acta Neuropathol; 1999 Feb; 97(2):113-8. PubMed ID: 9928821
[TBL] [Abstract][Full Text] [Related]
25. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide. An in vitro model of preamyloid.
Huang TH; Yang DS; Fraser PE; Chakrabartty A
J Biol Chem; 2000 Nov; 275(46):36436-40. PubMed ID: 10961999
[TBL] [Abstract][Full Text] [Related]
26. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
27. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
28. Spatial relationship of AMY protein deposits and different species of Abeta peptides in amyloid plaques of the Alzheimer disease brain.
Schmidt ML; Saido TC; Lee VM; Trojanowski JQ
J Neuropathol Exp Neurol; 1999 Dec; 58(12):1227-33. PubMed ID: 10604747
[TBL] [Abstract][Full Text] [Related]
29. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.
Stoltzner SE; Grenfell TJ; Mori C; Wisniewski KE; Wisniewski TM; Selkoe DJ; Lemere CA
Am J Pathol; 2000 Feb; 156(2):489-99. PubMed ID: 10666378
[TBL] [Abstract][Full Text] [Related]
30. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
[TBL] [Abstract][Full Text] [Related]
31. CLAC binds to aggregated Abeta and Abeta fragments, and attenuates fibril elongation.
Kakuyama H; Söderberg L; Horigome K; Winblad B; Dahlqvist C; Näslund J; Tjernberg LO
Biochemistry; 2005 Nov; 44(47):15602-9. PubMed ID: 16300410
[TBL] [Abstract][Full Text] [Related]
32. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
[TBL] [Abstract][Full Text] [Related]
33. Age-related plaque morphology and C-terminal heterogeneity of amyloid beta in Dutch-type hereditary cerebral hemorrhage with amyloidosis.
Maat-Schieman ML; Yamaguchi H; van Duinen SG; Natté R; Roos RA
Acta Neuropathol; 2000 Apr; 99(4):409-19. PubMed ID: 10787040
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
[TBL] [Abstract][Full Text] [Related]
36. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
37. Aβ38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models.
Reinert J; Martens H; Huettenrauch M; Kolbow T; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Bayer TA; Wirths O
J Alzheimers Dis; 2014; 39(4):871-81. PubMed ID: 24305500
[TBL] [Abstract][Full Text] [Related]
38. Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.
Howlett DR; Hortobágyi T; Francis PT
Brain Pathol; 2013 Nov; 23(6):623-32. PubMed ID: 23521156
[TBL] [Abstract][Full Text] [Related]
39. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
O'Callaghan P; Sandwall E; Li JP; Yu H; Ravid R; Guan ZZ; van Kuppevelt TH; Nilsson LN; Ingelsson M; Hyman BT; Kalimo H; Lindahl U; Lannfelt L; Zhang X
Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
[TBL] [Abstract][Full Text] [Related]
40. Surface plasmon resonance binding kinetics of Alzheimer's disease amyloid beta peptide-capturing and plaque-binding monoclonal antibodies.
Ramakrishnan M; Kandimalla KK; Wengenack TM; Howell KG; Poduslo JF
Biochemistry; 2009 Nov; 48(43):10405-15. PubMed ID: 19775170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
